Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Identification and characterization of phage-displayed peptide mimetics of Neisseria meningitidis serogroup B capsular polysaccharide.

Menéndez T, Santiago-Vispo NF, Cruz-Leal Y, Coizeau E, Garay H, Reyes O, Batista Y, Cobas K, Carmenate T, Chinea G, Guillén G.

Int J Med Microbiol. 2011 Jan;301(1):16-25. doi: 10.1016/j.ijmm.2010.04.020. Epub 2010 Aug 14.

PMID:
20708963
2.

Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization.

Lo Passo C, Romeo A, Pernice I, Donato P, Midiri A, Mancuso G, Arigò M, Biondo C, Galbo R, Papasergi S, Felici F, Teti G, Beninati C.

J Immunol. 2007 Apr 1;178(7):4417-23.

3.

Protective immunization against group B meningococci using anti-idiotypic mimics of the capsular polysaccharide.

Beninati C, Arseni S, Mancuso G, Magliani W, Conti S, Midiri A, Biondo C, Polonelli L, Teti G.

J Immunol. 2004 Feb 15;172(4):2461-8.

4.
5.

Purified capsular polysaccharide of Neisseria meningitidis serogroup A as immune potentiator for antibody production.

Menéndez T, Carmenate T, Cruz-Leal Y, Coizeau E, Caballero E, Bello D, Guirola M, Alvarez A, Guillén G.

Curr Microbiol. 2010 Feb;60(2):79-84. doi: 10.1007/s00284-009-9505-9. Epub 2009 Sep 23.

PMID:
19771476
6.

Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library.

Grothaus MC, Srivastava N, Smithson SL, Kieber-Emmons T, Williams DB, Carlone GM, Westerink MA.

Vaccine. 2000 Jan 18;18(13):1253-63.

PMID:
10649627
7.

Molecular mimetics of Neisseria meningitidis serogroup B polysaccharide.

Moe GR, Granoff DM.

Int Rev Immunol. 2001;20(2):201-20.

PMID:
11878765
8.

Study of various presentation forms for a peptide mimetic of Neisseria meningitidis serogroup B capsular polysaccharide.

Garay H, Menéndez T, Cruz-Leal Y, Coizeau E, Noda J, Morera V, Guillén G, Albericio F, Reyes O.

Bioconjug Chem. 2011 Jan 19;22(1):33-41. doi: 10.1021/bc100299g. Epub 2010 Dec 9.

PMID:
21141955
9.
10.
11.

Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine.

Carmenate T, Guirola M, Alvarez A, Canaán L, González S, Caballero E, Menéndez T, Guillén G.

FEMS Immunol Med Microbiol. 2005 Feb 1;43(2):133-40.

13.

New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.

Cuello M, Cabrera O, Martinez I, Del Campo JM, Camaraza MA, Sotolongo F, Pérez O, Sierra G.

Vaccine. 2007 Feb 26;25(10):1798-805. Epub 2006 Dec 5.

PMID:
17240485
14.

Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.

Fukasawa LO, Gorla MC, Schenkman RP, Garcia LR, Carneiro SM, Raw I, Tanizaki MM.

Vaccine. 1999 Aug 6;17(23-24):2951-8.

PMID:
10462229
15.

Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.

Park IH, Youn JH, Choi IH, Nahm MH, Kim SJ, Shin JS.

Infect Immun. 2005 Oct;73(10):6399-406.

17.

Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants.

Morley SL, Cole MJ, Ison CA, Camaraza MA, Sotolongo F, Anwar N, Cuevas I, Carbonero M, Campa HC, Sierra G, Levin M.

Pediatr Infect Dis J. 2001 Nov;20(11):1054-61.

PMID:
11734711
19.

Bordetella pertussis fimbriae are effective carrier proteins in Neisseria meningitidis serogroup C conjugate vaccines.

Reddin KM, Crowley-Luke A, Clark SO, Vincent PJ, Gorringe AR, Hudson MJ, Robinson A.

FEMS Immunol Med Microbiol. 2001 Aug;31(2):153-62.

20.

The immunogenicity of a conformationally restricted peptide mimetic of meningococcal lipooligosaccharide.

Tiwana H, Clow KJ, Hall C, Feavers IM, Charalambous BM.

Scand J Immunol. 2005 Oct;62(4):385-92.

Supplemental Content

Support Center